III. BMC Mol Biol. 12(1):43. Linkner, J., Witte, G., Stradal, T., Curth, U. and Faix, J. (2011) High-Resolution X-Ray Structure of the Trimeric Scar/WAVE-Complex Precursor Brk1 PLoS One 6, e21327 Winkler [...] switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design. Nat Commun 15(1): 411. Oleshko, O., N. Vollack-Hesse, A. Tiede, J. Hegermann, U. Curth and S. Werwitzke (2023). Von [...] and mechanistic basis of capsule O-acetylation in Neisseria meningitidis serogroup A. Nat Commun 11(1), 4723. Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., and

Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae. mBio. 2021 Jan 19;12(1):e03226-20. doi: 10.1128/mBio.03226-20. PMID: 33468699 Free PMC article. Kawanishi K, Saha S, Diaz S [...] ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis. J Clin Invest. 2021 Mar 1;131(5):e137681. doi: 10.1172/JCI137681. PMID: 33373330 Free PMC article. 2019 Niculovic KM , Blume L [...] (2018), Sialic acid is a critical fetal defense against maternal complement attack, J Clin Invest . 129(1), 422-436. Sieve I , Münster-Kühnel AK , Hilfiker-Kleiner D (2018), Regulation and function of endothelial

L, Kispert A, Al-Hasani H, Haffner D, Weber RG. Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary [...] Krauss JK, Feuerhake F, Hartmann C, Wiese B, Brand F, Weber RG. Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families. Acta Neuropathol Commun [...] Preller M, Aretz S, Wiese B, Hartmann C, Weber RG. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol

and Focus Group Study. Journal of Medical Internet Research 2025;27:e62750. URL: www.jmir.org/2025/1/e62750 . DOI: 10.2196/62750 Häberle N, Lander J , Dierks M-L, Bitzer EM (2024). Organisationale Ges [...] COVID-19 Pandemic: Scoping Review. J Med Internet Res 2024;26:e58566. URL: https:// www.jmir.org/2024/1/e58566 . DOI: 10.2196/58566 Lander J , Altawil H, Dilger E-M, Bruett AL, Fricke LM, Hoekstra D, John [...] com Vol 402 August 5, 2023. https:// www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01191-1/fulltext Lander J , Drixler K, Dierks M-L, Bitzer EM (2023). Gesundheitskompetenz von Menschen mit

Reddy S, Christgen M, and Zippelius A (2015). Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. Sci Transl Med 7:315ra188. Christgen M, Winkens W, and Kreipe [...] 104:1726-1730. Krech T, Scheuerer E, Geffers R, Kreipe H, Lehmann U, and Christgen M (2012). ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells [...] n of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17-24. Christgen M, Bruchhardt H, Ballmaier M, Krech T, Langer F, Kreipe H, and Lehmann U (2008). KAI1/CD82 is a novel target of estrogen

– Therapie – Gesundheit. Springer, Berlin, Heidelberg. S 391-402. doi.org/10.1007/978-3-662-54179-1_36-1 Röding D (im Erscheinen) Regionale Alternsbedingungen nach Surveydaten. In: Forkel JA, Grimm M, Elkeles [...] Birgel V, Groeger-Roth F, Brender R, Reder M, Feierabend N, Kleiner C, Walter U (2021). Results of the 1:1-matching of the CTC-EFF study: A non-randomized evaluation study, European Journal of Public Health [...] underlying domains and assessment methods. Systematic Reviews (2023) 12:147, DOI 10.1186/s13643-023-02314-1 Birgel V, Röding D , Reder M, Soellner R, Walter U (2023). Contextual effects of community capacity

Current Projects Molecular dissection of mutations in ACTB and ACTG1 causing non-muscle actinopathies Functional characterizations of mutations in non-muscle myosin-2A causing MYH9 -related disorders

Postanschrift Medizinische Hochschule Hannover Abteilung Freiwilligendienste OE 0009 Carl-Neuberg-Str. 1, 30625 Hannover Kontaktdaten Telefon: +49 511 532-5553 Fax: +49 511 532-165575 Freiwillige-Dienste.

Erkrankungen und Behandlungsspektrum Nävus flammeus Hämangiom, Spider-Nävus & Teleangiektasien Rosazea Grad 1-2 Narben und Keloide aktinische Keratosen und Cheilitis actinica Feldkanzerisierung Milien, Syringome

unserer internistischen Station 32 B mit rheumatologischem Schwerpunkt stehen aktuell 11 Betten (davon 1 Bett im Einzelzimmer) zur Verfügung. Unsere stationäre Diagnostik und Therapie umfasst das gesamte Spektrum